Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster model.
暂无分享,去创建一个
C Alonso | J. M. Requena | C. Alonso | J M Requena | M Soto | M D Doria | M. Soto | M. D. Dória
[1] G. Freeman,et al. Cloning of Syrian Hamster (Mesocricetus auratus) Cytokine cDNAs and Analysis of Cytokine mRNA Expression in Experimental Visceral Leishmaniasis , 1998, Infection and Immunity.
[2] F. Derouin,et al. Influence of the host and parasite strain in a mouse model of visceral Leishmania infantum infection. , 1998, FEMS immunology and medical microbiology.
[3] R. Killick-Kendrick,et al. Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum , 1994, Infection and immunity.
[4] F. Martínez-Moreno,et al. Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis. , 1995, Veterinary immunology and immunopathology.
[5] M. Roque-Barreira,et al. Immune complex glomerulonephritis in experimental kala‐azar , 1987, Parasite immunology.
[6] M. Roque-Barreira,et al. Immune complex glomerulonephritis in experimental kala‐azar II: Detection and characterization of parasite antigens and antibodies eluted from kidneys of Leishmania donovani‐infected hamsters , 1992, Clinical and experimental immunology.
[7] Y. Belkaid,et al. The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci. , 1996, Journal of immunology.
[8] H. Murray,et al. Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis. , 1995, The Journal of clinical investigation.
[9] A. C. Ghose,et al. Therapeutic and prophylactic uses of protein A in the control of Leishmania donovani infection in experimental animals. , 1999, Immunology letters.
[10] V. Rodrigues,et al. Transforming Growth Factor β and Immunosuppression in Experimental Visceral Leishmaniasis , 1998, Infection and Immunity.
[11] P. Bories,et al. Lack of a nitric-oxide response during the course of Leishmania infantum infection in the golden hamster (Mesocricetus auratus), with or without treatment with liposomal amphotericin B. , 1998, Annals of tropical medicine and parasitology.
[12] R. Vasconcellos,et al. Suppressor activity in Leishmania donovani-infected hamster serum: reversion by delipidated bovine serum albumin and role in cell cycle events. , 1996, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[13] R. Locksley,et al. The regulation of immunity to Leishmania major. , 1995, Annual review of immunology.
[14] C. Jaffe,et al. An experimental model for canine visceral leishmaniasis , 1991, Parasite immunology.
[15] R. López-Vélez,et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years , 1997, Clinical microbiology reviews.
[16] J. Keithly. Infectivity of Leishmania donovani amastigotes and promastigotes for golden hamsters. , 1976, The Journal of protozoology.
[17] Y. Schlein,et al. The effect of post-bloodmeal nutrition of Phlebotomus papatasi on the transmission of Leishmania major. , 1986, The American journal of tropical medicine and hygiene.
[18] L. Moldawer,et al. Role and effect of TNF-alpha in experimental visceral leishmaniasis. , 1994, Journal of immunology.
[19] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[20] J. M. Alunda,et al. Antibody response in dogs experimentally infected with Leishmania infantum: infection course antigen markers. , 1996, Experimental parasitology.
[21] C. Jaffe,et al. Analysis of immune responses in dogs with canine visceral leishmaniasis before, and after, drug treatment. , 1999, Veterinary immunology and immunopathology.
[22] J. Farrell,et al. Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters , 1989, Infection and immunity.
[23] P. Kaye,et al. Neutralization of IL‐12 demonstrates the existence of discrete organ‐specific phases in the control of Leishmania donovani , 1998, European journal of immunology.
[24] R. Pearson,et al. Clinical spectrum of Leishmaniasis. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] L. A. Stauber,et al. The origin and significance of the distribution of parasites in visceral leishmaniasis. , 1966, Transactions of the New York Academy of Sciences.
[26] F. Liew,et al. Immunology of leishmaniasis. , 1993, Advances in parasitology.
[27] J. van Lunzen,et al. Visceral leishmaniasis emerging as an important opportunistic infection in HIV-infected persons living in areas nonendemic for Leishmania donovani. , 1996, Archives of pathology & laboratory medicine.
[28] J. M. Requena,et al. Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis. , 1999, Veterinary immunology and immunopathology.
[29] F. Afrin,et al. Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes , 1997, Infection and immunity.
[30] J. Quaranta,et al. Visceral leishmaniosis in HIV‐positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T‐lymphocyte counts , 1998, AIDS.
[31] M. Riyad,et al. Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum. , 1999, Veterinary parasitology.